Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · IEX Real-Time Price · USD
1.235
+0.075 (6.47%)
At close: Jul 23, 2024, 3:59 PM
1.240
+0.005 (0.40%)
After-hours: Jul 23, 2024, 4:00 PM EDT

Chemomab Therapeutics Statistics

Total Valuation

CMMB has a market cap or net worth of $17.56 million. The enterprise value is $2.00 million.

Market Cap 17.56M
Enterprise Value 2.00M

Important Dates

The next estimated earnings date is Monday, August 12, 2024, before market open.

Earnings Date Aug 12, 2024
Ex-Dividend Date n/a

Share Statistics

CMMB has 14.22 million shares outstanding.

Shares Outstanding 14.22M
Owned by Insiders (%) 14.97%
Owned by Institutions (%) 23.83%
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE 13.00
PS Ratio n/a
Forward PS n/a
PB Ratio 1.32
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.83, with a Debt / Equity ratio of 0.03.

Current Ratio 3.83
Quick Ratio 3.83
Debt / Equity 0.03
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -109.90% and return on invested capital (ROIC) is -149.10%.

Return on Equity (ROE) -109.90%
Return on Assets (ROA) -83.70%
Return on Capital (ROIC) -149.10%
Revenue Per Employee n/a
Profits Per Employee -$966,800
Employee Count 20
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax -21,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -11.59% in the last 52 weeks. The beta is 0.20, so CMMB's price volatility has been lower than the market average.

Beta (5Y) 0.20
52-Week Price Change -11.59%
50-Day Moving Average 1.01
200-Day Moving Average 0.75
Relative Strength Index (RSI) 64.00
Average Volume (20 Days) 40,112

Short Selling Information

Short Interest 100,465
Short Previous Month 99,698
Short % of Shares Out 0.71%
Short % of Float n/a
Short Ratio (days to cover) 0.84

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -20.46M
Pretax Income -19.36M
Net Income -19.34M
EBITDA n/a
EBIT -19.36M
Earnings Per Share (EPS) -$1.56
Full Income Statement

Balance Sheet

The company has $15.95 million in cash and $390,000 in debt, giving a net cash position of $15.56 million or $1.09 per share.

Cash & Cash Equivalents 15.95M
Total Debt 390,000
Net Cash 15.56M
Net Cash Per Share $1.09
Equity (Book Value) 13.33M
Book Value Per Share 0.94
Working Capital 12.44M
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CMMB does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -28.58%
Shareholder Yield -28.58%
Earnings Yield -110.11%
FCF Yield n/a

Analyst Forecast

The average price target for CMMB is $5.67, which is 359.11% higher than the current price. The consensus rating is "Strong Buy".

Price Target $5.67
Price Target Difference 359.11%
Analyst Consensus Strong Buy
Analyst Count 3
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -53.27%
Stock Forecasts

Stock Splits

The last stock split was on March 17, 2021. It was a reverse split with a ratio of 1:16.

Last Split Date Mar 17, 2021
Split Type Reverse
Split Ratio 1:16

Scores

Altman Z-Score n/a
Piotroski F-Score n/a